(2,2-dimethyl-1-oxopropoxy)methyl ester sodium 2- (2- oxo- 2- ((3,7,11- trimethyl- 2,6,10- dodecatrienyl)oxy)aminoethyl)phosphonic acid

Also Known As:

2-(2-oxo-2-((3,7,11-trimethyl-2,6,10-dodecatrienyl)oxy)aminoethyl)phosphonic acid, (2,2-dimethyl-1-oxopropoxy)methyl ester sodium; FPT III cpd; farnesyl protein transferase inhibitor III, FPTIII; p21(ras) farnesyltransferase antagonist

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Organophosphorus Compounds: 300
  - Organophosphonates: 424
    - (2,2-dimethyl-1-oxopropoxy)methyl ester sodium 2-(2-oxo-2-((3,7,11-trimethyl-2,6,10-dodecatrienyl)oxy)aminoethyl)phosphonic acid: 1

Experts

1.	McPhaden, A R: 1 article (09/2001)
2.	Pyne, N J: 1 article (09/2001)
3.	Pyne, S: 1 article (09/2001)
4.	Wadsworth, R M: 1 article (09/2001)
5.	Wainwright, C L: 1 article (09/2001)
6.	Work, L M: 1 article (09/2001)

Related Diseases

1.	Neointima 09/25/2001 - "Our aim was to demonstrate in biochemical studies that farnesyl protein transferase inhibitor III (FPTIII) is an inhibitor of p21(ras) processing and that when it is given locally in vivo at the site of coronary balloon injury in a porcine model, it can inhibit neointima formation. "

Related Drugs and Biologics

1.	Proto-Oncogene Proteins p21(ras)